sGC is therefore a hot target for designing novel drugs to cure the disorders associated to cGMP signaling pathway such as peripheral hypertension, pulmonary arterial hypertension (PAH), heart failure and liver fibrosis [10,11]. Here, SGCB is linked to pulmonary arterial hypertension.